In the last trading session, 0.47 million shares of the Unicycive Therapeutics Inc (NASDAQ:UNCY) were traded, and its beta was 2.02. Most recently the company’s share price was $0.55, and it changed around $0.0 or 0.75% from the last close, which brings the market valuation of the company to $66.73M. UNCY currently trades at a discount to its 52-week high of $1.01, offering almost -83.64% off that amount. The share price’s 52-week low was $0.20, which indicates that the current value has risen by an impressive 63.64% since then.
Unicycive Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 7 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 0 recommended UNCY as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight. Unicycive Therapeutics Inc is expected to report earnings per share of -0.07 for the current quarter.
Unicycive Therapeutics Inc (NASDAQ:UNCY) trade information
Instantly UNCY has showed a green trend with a performance of 0.75% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.6200 on recent trading dayincreased the stock’s daily price by 11.29%. The company’s shares are currently down -30.35% year-to-date, but still down -7.17% over the last five days. On the other hand, Unicycive Therapeutics Inc (NASDAQ:UNCY) is -13.56% down in the 30-day period.
6 analysts expect Unicycive Therapeutics Inc to make 4.83M in revenue for the current ending quarter. Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -31.80%.
UNCY Dividends
Unicycive Therapeutics Inc’s next quarterly earnings report is expected to be released in June.
LOGOS GLOBAL MANAGEMENT LP, with 9.9389% or 3.47 million shares worth $1.74 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 765.0 shares worth $0.42 million, making up 0.63% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held roughly 373.22 shares worth around $0.21 million, which represents about 0.31% of the total shares outstanding.
